SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Nantes - Systemy Nanotechnologii
Nantes - Systemy Nanotechnologii Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Nantes - Systemy Nanotechnologii Spółka z Ograniczoną Odpowiedzialnością
Nantes - Systemy Nanotechnologii Spółka z Ograniczoną Odpowiedzialnością (KRS 0000278255, NIP 6121792291) is a Polish company, headquartered in Bolesławiec, Dolnośląskie voivodeship. NANTES - SYSTEMY NANOTECHNOLOGII operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since April 6, 2007. NANTES - SYSTEMY NANOTECHNOLOGII's most recently reported net revenue was 708.3 K PLN for 2024.
Bankruptcy proceedings
Bankruptcy proceedings are underway against the company.
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Credibility rating
35.6 / 100
Poor credibility
Insolvency risk
Low
Elevated threat
Closure risk
27
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
4
4/19 yrs
Board changes
5
5/19 yrs
PKD changes
5
5/19 yrs
Name changes
0
0/19 yrs
Data from 19 years of registry activity.
Payment reliability score from 2018–2024
Current: E (36/100)
Trend: deteriorating (-17.1 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Standard limit from 2018–2024
Current: 7.6 K PLN
Safe: 1.5 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
April 6, 2007
19 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
BOLESŁAWIEC
DOLNOŚLĄSKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
50.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Proxies: 1
Filed years
7 years
2018–2024 · profitable: 4/7
Registry entries
45
latest: October 30, 2025
Risk signals
Revenue
708.3 K PLN
2024
Net profit
-138.7 K PLN
2024
Assets
1.1 M PLN
2024
Equity
N/A
2024
EBITDA
19.0 K PLN
2024
Valuation
103.7 K PLN
Low confidence
Low confidence
Rate business credibility - Nantes - Systemy Nanotechnologii.
No ratings
News
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
NANTES - SYSTEMY NANOTECHNOLOGII's board has 1 member.
20 historical registry entries for Nantes - Systemy Nanotechnologii
Filing documents submitted (2 documents)
Shareholder change
WR.IX NS-REJ.KRS/16222/24/93
Change in Section 1 (basic data)
WR.IX NS-REJ.KRS/16222/24/93/ADE
Filing documents submitted (2 documents)
Change in Section 4 (arrears and enforcement)
WR.IX NS-REJ.KRS/13745/25/233
Latest reporting year
2024
Available years
17
Filing entries
0
Competing companies or those operating in the same market segment as Nantes - Systemy Nanotechnologii (in Bolesławiec, industry: Research and development).
WROCŁAW· Research and development
Revenue 2024: 83.2 M PLN
WROCŁAW· Research and development
Revenue 2024: 31.7 M PLN
WROCŁAW· Research and development
Revenue 2025: 31.6 M PLN
WROCŁAW· Research and development
Revenue 2024: 16.3 M PLN
WROCŁAW· Research and development
Revenue 2025: 15.6 M PLN
WROCŁAW· Research and development
Revenue 2024: 12.0 M PLN
